- to
monotherapies, and the FDA
recently approving therapeutic combination regimens that
demonstrated superior safety and
efficacy to
monotherapies. In...
-
advanced prostate cancer (LAPC) as a
monotherapy without castration.
Bicalutamide was also
previously used as
monotherapy to
treat localized prostate cancer...
- A2A
receptor that was
previously under development by
Kyowa Kirin as a
monotherapy and
adjunctive to
levodopa therapy in Parkinsonism. KW-6356 is a selective...
-
combination of
interventions has been
shown to be more
effective than
monotherapy in
achieving tobacco cessation. In addition,
behavioral interventions...
- and Drug
Administration (FDA) to
treat bipolar depression,
either as
monotherapy or
adjunctively with
lithium or valproate. It has no
effect on manic...
-
systemic review found no
evidence to
support the use of
lithium for
monotherapy.
Lithium is
widely believed to
prevent suicide and is
often used in clinical...
-
treatment of
schizophrenia as well as
bipolar depression, as
either monotherapy or
adjunctive therapy (with
lithium or valproate). It is
developed by...
-
generalized tonic clonic seizure.
Despite this it is also
sometimes used as a
monotherapy for partial-onset seizures. In 2020, it was the 276th most
commonly prescribed...
- well-studied and characterized. The most
common side
effects of
bicalutamide monotherapy in men
include breast tenderness,
breast growth, feminization, demasculinization...
-
Stanley DA,
Kanekiyo M,
Wollen S, et al. (March 2016). "Protective
monotherapy against lethal Ebola virus infection by a
potently neutralizing antibody"...
